Advanced mass spectrometry for analyzing biological samples
Thermo IQ-X high-resolution mass spectrometer
This study is all about getting a new, high-tech machine to help scientists better understand diseases like cancer by looking closely at tiny biological markers in samples, which could lead to better ways to diagnose and treat patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10854283 on NIH RePORTER |
What this research studies
This research focuses on acquiring a state-of-the-art mass spectrometer to enhance the analysis of biological samples, particularly in the fields of lipidomics and metabolomics. The instrument will be used to identify and quantify various biological markers, which can help in understanding diseases such as cancer and chronic illnesses. By collaborating with over 80 investigators, the project aims to provide advanced analytical capabilities that can lead to better diagnostics and treatment strategies. Patients may benefit from improved understanding and management of their conditions through the insights gained from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include patients with chronic diseases, cancers, or those involved in studies related to lipid and metabolic disorders.
Not a fit: Patients with acute conditions or those not related to lipidomics or metabolomics may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostics and personalized treatment options for patients with various diseases.
How similar studies have performed: Previous research utilizing high-resolution mass spectrometry has shown significant success in advancing our understanding of complex biological systems, indicating that this approach is both promising and validated.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Mesaros, a. Clementina — University of Pennsylvania
- Study coordinator: Mesaros, a. Clementina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.